D'Souza Rupert 4
4 · Adverum Biotechnologies, Inc. · Filed May 17, 2022
Insider Transaction Report
Form 4
D'Souza Rupert
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-05-13$0.86/sh+10,000$8,585→ 10,850 total - Purchase
Common Stock
2022-05-17$0.83/sh+10,000$8,272→ 20,850 total
Footnotes (2)
- [F1]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.856 to $0.865. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.8245 to $0.828. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.